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Betaine–homocysteine S-methyltransferase (BHMT) activity is only detected in the liver of rodents, but in both
the liver and kidney cortex of humans and pigs; therefore, the pig was chosen as a model to define the spatial
and temporal expression of BHMT during development. During fetal development, a total of ten splice variants
of bhmtwere expressed at varying levels across a wide range of porcine tissues. Two variants contained an iden-
tical ORF that encoded a C-terminal truncated form of BHMT (tBHMT). The bhmt transcripts were expressed at
significant levels in the liver and kidney from day 45 of gestation (G45) onward. The transcripts encoding
tBHMT represented 5–13% of the total bhmt transcripts in G30 fetus, G45 liver, and adult liver and kidney cortex.
The dominant structural feature of wild type BHMT is an (βα)8 barrel, however, a modeled structure of tBHMT
suggests that this proteinwould assume a horseshoe fold and lackmethyltransferase activity. Low BHMT activity
was detected in the G30 fetus, and slightly increased levels of activity were observed in the liver from G45 and
G90 fetuses. The bhmt promoter contained three key CpG sites, and methylation of these sites was significantly
higher in adult lung compared to adult liver. The data reported herein suggest that genomic DNA methylation
and variation of the 5′ and 3′ UTRs of bhmt transcripts are key regulators for the level of BHMT transcription
and translation.
© 2013 Elsevier B.V. All rights reserved.
1. Introduction
Elevated levelsofhomocysteine (Hcy) inblood,hyperhomocysteinemia,
has been associated with an increased risk for vascular disease and
thrombosis (Refsum et al., 1998) and neural tube defects and adverse
pregnancy outcomes, including spina bifida and placental abrup-
tions (Ananth et al., 2007; Eskes, 1998; Hague, 2003; James et al.,
1999; Mills et al., 1995; Steegers-Theunissen et al., 1991). Hcy
resides at a metabolic branch point; it can proceed through the
transsulfuration pathway to participate in cysteine biosynthesis or
it can be remethylated to form methionine, the amino acid from
which it was derived. Hcy remethylation is important to sustain
adequate Met availability for the synthesis of S-adenosylmethionine,
the required methyl donor for hundreds of S-adenosylmethionine-
dependent methyltransferase enzymes found in mammals (Petrossian
and Clarke, 2011). There are nutritional conditions and genetic factors
known to reduce Hcy remethylation and cause hyperhomocysteinemia,
presumably increasing disease risk.
There are three cytosolic enzymes in mammals that remethylate
Hcy; methionine synthase (EC 2.1.1.13), betaine–homocysteine S-
methyltransferase (BHMT, EC 2.1.1.5), and the recently characterized
BHMT-2 (EC 2.1.1.5) (Szegedi et al., 2008). Methionine synthase is a
cobalamin-dependent enzyme that uses 5-methyltetrahydrofolate as
the methyl donor. BHMT uses betaine, whereas BHMT-2 uses S-
methylmethionine, as its methyl donor. Methionine synthase is a low
abundance protein whose activity can be detected in nearly every
mammalian tissue. However, BHMT and BHMT-2 activities are largely
restricted to the liver, and in some species, kidney or pancreas, but the
detection of these enzymes can be hampered by their low turnover
numbers, which are about a 1000-fold less than methionine synthase
(Garrow, 1996; Millian and Garrow, 1998; Szegedi et al., 2008).
Much is known about the structure of BHMT since the crystal struc-
tures of the human (Evans et al., 2002) and rat (Gonzalez et al., 2004)
enzymes have been solved. In brief, the primary sequence of BHMT is
encoded by ~400 amino acids and its quaternary structure is a tetramer
composed of a dimer of dimers. The first three-quarters of the ORF en-
code a (β/α)8 barrel that contains all but one of the known residues
that form the active site, including residues Cys217, Cys299 and
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Cys300, which are required for binding the enzyme's catalytic zinc, as
well as Gln159, an invariant residue in this family of enzymes required
for Hcy binding. The C-terminal region, defined as the last quarter of
the ORF, encodes structures required for oligomerization (Evans et al.,
2002; Gonzalez et al., 2004).
It is unclear why mammals have three cytosolic enzymes that
methylate Hcy, and little is known regarding their relative contribu-
tions to methionine biosynthesis and how their contributions might
change with physiological state or diet, or how their expression in
various tissues might change throughout development. With re-
spect to BHMT, one other known physiological function is to regu-
late betaine concentrations in liver and kidney (Delgado-Reyes
and Garrow, 2005). Relative to the low abundance of methionine
synthase, it is intriguing that BHMT represents up to 1% or more of
the total soluble protein in adult liver (Garrow, 1996). Is it possible
that BHMT has a moonlighting function(s) yet to be discovered?
An alternative function could explain why BHMT has not evolved
to be a more efficient catalyst, or why mammalian liver expresses
so much BHMT since its activity and cellular location is redundant
to methionine synthase.
The pig has been established as a good animalmodel to study several
human diseases including diabetes, Alzheimer's disease, and cancer
(Tumbleson and Schook, 1996). Since pigs express BHMT in the same
adult organs as humans (Sunden et al., 1997), we chose to use them
as a model to identify and explore the spatial and temporal expression
of bhmt transcripts arising throughout development, and gain clues re-
garding a potential moonlighting function(s) for its gene product(s).
Variation in heteronuclear RNA splicing can increase protein diversity
and more than three quarters of mammalian genes are alternatively
spliced (Johnson et al., 2003). This report is the first to describe and
quantify bhmt splice variants during pig development, including
two variants that when translated would encode a truncated protein
predicted to have no methyltransferase activity. We also report that
promoter methylation and length variation of the bhmt 5′ and 3′ UTRs
probably have important roles in regulating the expression level of
BHMT in different tissues.
2. Materials and methods
2.1. BHMT enzyme assay
The BHMT assay was performed using the method described by
Garrow (Garrow, 1996) with the following modifications. The betaine
concentration used was 250 μM and the incubation was performed at
37 °C for 30 min for adult liver, fetal (G45 and G90) liver and adult kid-
ney cortex, and 2 h for G30 fetus, and G45 and G90 kidney, lungs, heart
and brain and adult lungs, heart and brain tissues. The incubation time
for liver samples was reduced since BHMT activity is highest in liver.
Samples from three animals were analyzed separately for each tissue.
The negative control (no enzyme added) in the experiment was used
as blank and the values were normalized to the amount of protein
present in the tissue using Bradford method thereby determining the
specific activity.
2.2. RNA extraction and cDNA preparation
Tissues were obtained from adult (sexually mature) and fetal ges-
tation days 30, 45 and 90 from three Yorkshire pigs. The tissues at
these developmental stages (whole fetus was used for analyzing
gestation day 30) were liver, kidney cortex, kidney medulla, lungs,
heart, and brain. Total RNA was isolated from frozen tissues using the
RNeasy Mini Kit (Qiagen, Valencia, CA). Reverse transcription was
carried out using random primers and the Bioline cDNA synthesis kit
(Taunton, MA).
2.3. Cloning and sequencing BHMT splice variants (SV)
Based on the exonic regions of the porcine bhmt gene, cDNAs that to-
gether encode the complete ORF of BHMTwere amplified using the fol-
lowing three primer sets (Table 1); 1-F/1-R, 2-F/2-R, and 3-F/3-R (Ganu
et al., 2011). Then, the 5′ and 3′ untranslated regions of bhmt transcripts
from various tissues were amplified using total RNA and the
FirstChoiceTM RNA ligase-mediated (RLM)-RACE kit (Ambion, Austin,
TX). This procedure used primers supplied with the kit and the nested
gene-specific primers listed in Table 1. The 5′ UTRs from all tissues
were obtained using the B1-5r-outer/5′-RACE-outer and B1-5r-inner/
5′ RACE inner primer sets. The 3′ UTR from liver was obtained using
the B1-3r-outer/3′-RACE-outer and B1-3r-inner/3′ RACE-inner primer
sets (Ganu et al., 2011). The 3′ UTRs from adult kidney medulla, lung,
brain and heart were isolated following two rounds of amplifica-
tion with the following primer sets; B1-Sv-3r-outer/3′-RACE-outer
and B1-Sv-3r-inner/3′-RACE-inner. These products were cloned into
pCRTOPO2.1 vector and sequenced. The sequences of bhmt splice vari-
ants were submitted to NCBI genbank. SV1 (HQ130333) was previously
reported (Ganu et al., 2011) but the accession numbers of the others are
SV2 (JX988430), SV3(JX988431), SV4(JX988432), SV5(JX988433),
SV6(JX988434), SV7(JX988435), SV8(JX988436), SV9(JX988437) and
SV10(JX988438). The cDNAs and deduced amino acid sequences were
Table 1
List of primers used for amplifying.
Primer name Primer sequence Tm Experiment
B1-Sv-3r-outer CCTTGAAAGCATCTGGGAAG 60 RLM-RACE
B1-Sv-3r-inner GCTCATGAAAGAAGGCTTGC 60 RLM-RACE
B1-5r-outer TCCGTCTCCAATCACAACCT 60 RLM-RACE
3′RACE-outer Supplied with kit 60 RLM-RACE
3′RACE-inner Supplied with kit 60 RLM-RACE
5′RACE-outer Supplied with kit 60 RLM-RACE
5′RACE-inner Supplied with kit 60 RLM-RACE
BHMT-exon6-7-F GGTTCATCGACCTGCCAGAA – Real-time RT-PCR
BHMT-exon6-7-R GAATGTCCCATCTGGTTGCAA – Real-time RT-PCR
BHMT-exon6-8-F GCAAACAGTGAAGCTCATGAAAGA – Real-time RT-PCR
BHMT-exon6-8-R CATCCGGCTTTGACATGGA – Real-time RT-PCR
BHMT-exon6-8-probe AGGCCATACAACCC – Real-time RT-PCR
Mp-1f GTTTTTTATATTTTTATAATTAGAGGA 55.3 Bisulfite sequencing
Mp-1r AACTCCCTACCTACAAAATCCTC 55.3 Bisulfite sequencing
Mp-2f GATTTTGTAGGTAGGGAGTT 55.3 Bisulfite sequencing
Mp-2r AAACCCAATAAAAACCCTACAACTT 55.3 Bisulfite sequencing
Mp-3f TTTTTTTGGTTTTTTTGTTTTTAAT 52.8 Bisulfite sequencing
Mp-3r AACAAATAACAACCTACTTATTTTT 52.8 Bisulfite sequencing
Mp-4f GGGGTTATATAGTTTTAGGGGG 55.9 Bisulfite sequencing
Mp-4r ACCAAAAAAATAAATCTACAAAAACC 55.9 Bisulfite sequencing
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analyzed using the Biology Workbench (http://workbench.sdsc.edu/).
The mRNA secondary structures and free energy values were predicted
using theMFOLD software program (version 3.2; http://www.bioinfo.
rpi.edu/applications/mfold)(Zuker, 2003). Poly AH software (http://
www.softberry.ru/berry.phtml) was used to detect poly A signal
sites. Potential miRNA sites were identified using miRwalk (http://
www.umm.uni-heidelberg.de/apps/zmf/mirwalk/predictedmirnagene.
html). MiRWalk also compares additional miRNA predicting algorithms
such as miRanda, miRDB, PITA, RNAhybrid, RNA22. TargetScan algo-
rithm was used to predict miRNA sites (http://www.targetscan.org/).
The putative tBHMT protein was modeled using Phyre software
(www.sbg.bio.ic.ac.uk/~phyre/), and visual depictions were generated
using the PyMOL Molecular Visualization System (DeLano Scientific
LLC, Palo Alto, CA). The pdb code of the structure used as a 3D template
for the homology modeling is 1LT8.
2.4. Real-time RT-PCR of porcine BHMT SVs
SVs were quantified by RT-PCR using the SYBR Green PCR
Mastermix. Total mRNA was treated with RNase-free DNAse (Qiagen,
Valencia, CA) to eliminate genomic contamination. Reverse transcrip-
tion was then performed using the OmniscriptKit (Qiagen, Valencia,
CA) (Chen et al., 2006). The primers used to quantify the bhmt transcrips
(Table 1) were designed using Primer Express software (Applied
Biosystems, Foster City, CA). The total amount of bhmtmRNA (all splice
variants) in a given tissuewas determined using the qBHMT-f/qBHMT-r
primer set (Ganu et al., 2011). Transcripts sharing the exon 6–exon 7
junction (SV1, SV2, SV4, SV5, SV7, SV8, SV9 and SV10) were measured
using a primer located at the 3′ end of exon 6 (BHMT-exon6-7-F) and
another primer annealing with the 5′ end of exon 7 (BHMT-exon6-7-
R). In order to accurately quantify the truncated splice variants (SV3
and SV6), a Taqman 5′ nuclease assay (Applied Biosystems, Foster
City, CA) using the BHMT-exon6-8-F/BHMT-exon6-8-R primer set was
performed. The probe (BHMT-exon6-8-probe) was designed to anneal
to the specific exon 6–exon 8 junction found only in SV3 and SV6.
Using these data, the percentage of transcripts encoding wild type
(WT) BHMT (SV1, SV2, SV4, SV5, SV5, SV7, SV8 and SV9) and tBHMT
(SV3 and SV6) were determined. Three replicates were performed for
each sample. Each reaction contained 100 ng of cDNA. The negative con-
trols (minus template or reverse transcriptase) were run in triplicate.
Data was normalized using 18S ribosomal RNA as an internal control
and to the amount of genomic DNA/tissue/sample (Chen et al., 2006).
The parameters used for qPCR were 50 °C for 2 min followed by 95 °C
for 10 min, 40 cycles with 95 °C for 15 s, 60 °C for 1 min, final cycle of
95 °C for 15 s, 60 °C for 15 s and 95 °C for 15 s. Splice variants were
cloned into pCR2.1-TOPO (Invitrogen, Carlsbad, CA), verified by sequenc-
ing and used for the construction of a standard curve. The qRT-PCR assay
was performed using the ABI 7900HT fast real-time PCR system (Applied
Biosystems, Foster City, CA). Statistical analyses were performed using
ANOVA (p b 0.01).
2.5. Bisulfite sequencing of bhmt CpG island
Genomic DNA was isolated from the liver and lung of three adult
pigs (sexually mature; 7 months) and three G90 embryos. The EpiTect
Bisulfite Kit (Qiagen, Valencia, CA) was used for bisulfite conversion of
genomic DNA. The primers given in Table 1 were used to amplify the
bhmt CpG island. The PCR program used for primer Mp-1, Mp-2, and
Mp-4 was 94 °C for 5 min, 94 °C for 30 s, 52–56 °C for 30 s, 72 °C for
1 min and 72 °C for 10 min. The PCR program used for primer Mp-3
was 94 °C for 5 min, 94 °C for 30 s, 52.8 °C for 3 min, 72 °C for 1 min
and 72 °C for 10 min. A total of 35 cycles were performed all PCR reac-
tions. The PCR products were then cloned into pCR2.1-TOPO
(Invitrogen, Carlsbad, CA), sequenced using ABI Big Dye, and the per-
centage of methylated (CpG) sites was determined. A total of 24 clones
were sequenced using aminimumof 4 clones fromeach animal. For G90
liver primer set Mp-3, a total of 23 clones were sequenced with a min-
imum of 6 clones from each animal.
3. Results
3.1. BHMT enzymatic activity during development
BHMT activity was greater in adult liver (123 U/mg) followed by
adult kidney cortex (28 U/mg). Adult kidney medulla and brain had
low activity (5 U/mg), whereas adult lung had no detectable activity.
The amount of BHMT activity in whole G30 fetus was ~3 U/mg, and
fetal liver at G45 and G90 had 5 and 11 U/mg, respectively (Fig. 1).
There was no detectable BHMT activity in kidney, lungs, heart and
brain tissues of G45 and G90 fetuses.
Fig. 1. BHMT enzyme activity during development in different tissues. The gray bars represent the specific activity of BHMT methyltransferase activity in units/mg protein. Total protein
content was measured using Bradford assay. The error bars represent standard deviation observed from three different animal samples.
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3.2. Analysis of bhmt splice variants and deduced amino acid sequences
Analysis of total RNAobtained fromadult liver, kidney cortex, kidney
medulla, lungs, heart and brain revealed the presence of ten bhmt splice
variants (Fig. 2). SV1 has beenpreviously reported in (Ganu et al., 2011).
The entire ORF encoded by the bhmt gene is composed of 8 exons
(1224 bp) and encodes a protein of 407 amino acids (45 kD) (Ganu
et al., 2011). Seven of the nine variants encoded this protein, which is
consistent with the enzymes purified from rat (Gonzalez et al., 2004),
pig (Sunden et al., 1997) and human liver (Garrow, 1996). Interestingly,
two splice variants (SV3 and SV6) encode an identical ORF that is miss-
ing the latter half of exon 6, all of exon 7, and the beginning of exon 8
compared to the other SV. If translated, these variants would encode a
tBHMT protein composed of 255 residues (28 kD).
3.3. 5′UTR and 3′UTR analyses
The varying lengths of the 5′ and 3′ UTRs of the SVs are depicted in
Fig. 2, and their precise lengths as well as the length of the coding re-
gions for individual SVs are given in Table 2. The 5′UTRswere predicted
to have secondary structures with free energies ranging from −19.5
(SV1; liver) to −56.5 to −59.4 kcal/mol (SV5/6; heart). Using miRNA
predicting softwares (miRWalk,miRanda,miRDB and Targetscan), a po-
tential miRNA (mmu-miR-686) was found in a mouse BHMT 3′ UTR
(NM_016668), and this potential miRNA is conserved in the 3′ UTR of
porcine (SV1 and SV8) that are detected in the liver and kidney cortex.
3.4. Tissue-specific expression analyses of porcine BHMT splice variants
To compare the expression levels of the SV in different tissues, the
primer pairs listed in Table 1 were used for real-time PCR analysis. The
total expression of bhmt transcripts is provided in Table 3. Consistent
with activity measurements, adult liver expressed the highest levels of
bhmt mRNA followed by the kidney cortex. The kidney medulla and
lungs expressed lower (p b 0.01) transcript levels, and adult heart and
brain had the lowest levels. In G45 fetal tissues, the transcript expres-
sion pattern followed the same trend,with the liver and kidney express-
ing high levels with comparatively lower levels observed in lungs, heart
and brain. In G90 fetal tissues, high levels of bhmtmRNAwere observed
in the porcine liver and kidney, but no transcripts were detected in the
lungs, heart and brain. The relative ratio of transcripts with exon 7 (SV1,
2, 4, 5, 7, 8 and 9), which encode the wild type BHMT, relative to those
without exon 7 (SV3, 6), which encode tBHMT, is given in Table 4. Since
adult liver expresses high levels of bhmtmRNA, the expression level of
the isoforms that encode tBHMT were biologically significant. In some
tissues, the total of SV3/6 and SV1/2/4/5/7/8/9/10 exceeded the number
of total bhmt transcripts (detected using primers in exon4) indicating
that there could be additional SV that have not been detected by our
screening methods. The total bhmt transcript expression in a given
organ was strongly correlated to that organ's level of BHMT activity
(R2 = 0.68), however, because all of the variants that can code for an
active enzyme only differed in their 5′ and 3′ UTRs, it is not possible to
determine if a given transcript(s) more reliably predicts activity within
a given tissue.
3.5. Modeled structure of tBHMT
Two splice variants (SV3 and SV6) isolated from the kidney medulla
and heart, respectively, were found to contain an identical ORF thatwas
significantly shorter than the ORF encoded by the other SVs, including
the primary isoform found in liver (SV1), which defines the wild type
protein. Based on its primary sequence, if efficiently translated and
stable, tBHMT would lack methyltransferase activity since it lacks key
residues required for catalysis, including Cys299 and Cys300, both of
which are required for zinc binding, and in turn is required for Hcy
binding and therefore catalysis (Breksa and Garrow, 2002; Evans et al.,
2002). Furthermore, tBHMT also lacks sequences that encode the
C-terminal region of wild type BHMT that are required for oligomer-
ization, suggesting that tBHMT would be present as a monomeric
protein. The translated tBHMT peptide was modeled based on hBHMT
Fig. 2. Splice variants (SV) of bhmt gene. The black boxes represent the 5′ UTR, light gray
boxes numbered 1–8 represent the exon 1–8 and the dark gray boxes represent the 3′
UTR. In addition to coding sequence, exon 1 and exon 8 include the 5′ UTR and 3′ UTR,
respectively. The black vertical lines depict region coding for the enzymatic region of
BHMT protein and black dotted region depicts the oligomerization domain. The letters
represent L (liver), KC (kidney cortex), KM (kidney medulla), Lu (lungs), H (heart), B
(brain).
Table 2
Length of UTRs and coding region of BHMT splice variants.
Splice
variant
5′ UTR
(nucleotide)
Coding region
(nucleotides)
3′ UTR
(nucleotide)
1 77 1224 1142
2 77 1224 79
3 77 768 161
4 77 1224 74
5 162 1224 79
6 162 768 161
7 74 1224 79
8 77 1224 927
9 77 1224 79
10 74 1224 74
Table 3
Expression of total bhmt transcripts using qRT-PCR.
Age Tissue Average bhmt
transcripts/100 ng
cDNA
Standard
deviation
g30 G30fetus 40,509 18,030
g45 Liver 127,199 56,613
Kidney medulla Not detectable –
Kidney cortex 136,922 64,710
Lungs 27,546 12,260
Heart 14,583 6491
Brain 1620 721
g90 Liver 401,852 178,854
Kidney medulla Not detectable –
Kidney cortex 203,357 90,509
Lungs 4861 2164
Heart Not detectable –
Brain Not detectable –
Adult Liver 1,675,464 745,705
Kidney medulla 288,750 128,515
Kidney cortex 1,453,473 646,903
Lungs 116,667 51,925
Heart 76,157 33,896
Brain 15,799 7032
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(PDB 1LT8) using the Phyre server (Kelley and Sternberg, 2009) while
molecular figures were created with PyMOL (Schrodinger, 2010)
(Fig. 3). The model suggests that tBHMT is missing the N-terminal
α-helix, β-strand and αB helix, as well as the C-terminal α-helix
and β-strand of the wild type enzyme, and that tBHMT assumes a
horseshoe rather than a barrel fold.
3.6. Analysis of methylation status of CpG islands
A CpG island (865 bp with 64.9% GC content) was detected in the
porcine bhmt gene. This island is located 100 bp upstream of the trans-
lational start site and contains exon 1 and part of intron 1. The methyl-
ation status of adult andG90 fetal liver and lungswas studied in order to
understand if methylation could be a factor contributing to the spatial
and temporal regulation of bhmt gene since mRNA and enzyme activity
are abundant in liver and kidney cortex. The CpG island was cloned
using primers that amplified four overlapping regions (Fig. 4).
The overall methylation of the CpG island was 5.7% for adult liver
and 19.1% for adult lungs. The key sites of methylation were −10,
−67 and−69, which are part of the consensus T-Ag and M2F1 tran-
scription factor binding sites. In adult liver, none of these sites were
methylated except in one out of 24 clones (CpG located −69; 3%
methylation). The part of CpG island contained within the promoter
region in adult liver was not methylated. In the case of adult lungs
the CpG sites located at −10, −67 and −69 were 13.26%, 39.32%
and 33.18% methylated, respectively. Thus, the level of methylation
Table 4
Relative ratio of presence of splice variants.
G30 (whole fetus) G45 G90 Adult
Liver SV (6–7) 90% 94% 86% 88%
Liver SV (6–8) 10% 6% 13%⁎ 12%
Kidney cortex
SV (6–7)
- 86% 100% 92%
Kidney cortex
SV (6–8)
– 13% ND 8%
Kidney medulla
SV (6–7)
– ND ND 100%
Kidney medulla
SV (6–8)
– ND ND ND
Lungs
SV (6–7)
– ND ND 100%
Lungs
SV (6–8)
– ND ND ND
Heart
SV (6–7)
– ND ND 24%
Heart
SV (6–8)
– ND ND ND
ND = splice variants below detection levels.
6–7 = splice variants sharing exon 6–7 junction.
6–8 = splice variants sharing exon 6–8 junction.
⁎ = Average of three replicates from one animal.
Fig. 3. Structure of hBHMT (PDB 1LT8) andmodeled structure of tBHMT. (A) and (B) show the structure of wild type human BHMT (barrel only), and (C) and (D) show the Phyre-
generated model of the truncated form of porcine BHMT (tBHMT). (E) Dimer of hBHMT where the two monomers are shown in cartoon and displayed in blue and yellow. Zn
atoms are shown in gray spheres. The regions highlighted in orange and light blue are equivalent to the regions missing in the porcine BHMT SV1 and SV6 variants. These regions
are involved in extensive dimerization interactions. (F) Two tBHMT monomers were superimposed to the two momoners comprising the hBHMT dimer. It is clear that tBHMT
lacks important residues that would promote dimerization in a manner similar to that of the full-length enzyme.
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is correlated to the expression of bhmt gene in adult liver and lungs.
Transcription of the bhmt gene in liver was 40-fold higher than in
adult lungs. The overall methylation of the CpG island was 10.25%
for G90 liver and 15.15% for G90 lungs. The part of CpG island
contained within the promoter region of fetal liver was 13.8% meth-
ylated but was 20.83% in fetal lungs. No specific methylation pattern
was observed for the fetal pigs indicating that methylation could be a
factor for regulation only in adulthood.
4. Discussion
Aprevious study reported that BHMTmRNA (via Northern analysis),
activity, and immunodetectable protein could only be detected in the
liver and kidney cortex of adult pigs (Ganu et al., 2011; Sunden et al.,
1997). Using adult pig tissues, this study confirms that most of the
BHMT activity in pigs is sequestered to these adult organs. However,
due to the increased sensitivity of PCR, we have characterized a total
of ten bhmt SVs that were expressed in a variety of adult and fetal por-
cine tissues. The SVs differed in the length of their 5′ and 3′ UTRs, and
two variants encoded the same novel ORF, that if effectively translated,
would encode a C-terminal truncated form of BHMT. Furthermore, it
would not be possible for the tBHMT protein to have methyltransferase
activity since missing residues are required for binding its catalytic zinc.
TheUTRs and coding regions of the different SV are depicted in Fig. 2,
and their precise lengths are given in Table 2. Sequence analyses pre-
dicted that the free energy for the secondary structure of the leader se-
quence encoded by the dominant variant in liver (SV1), which is where
BHMTmRNAand activity aremost abundant, is only−19.5 kcal/mol. In
contrast, the free energies for the secondary structures predicted for the
leader sequences found in heart (SV5 and SV6), where dramatically
lower levels of BHMT mRNA and activity were observed, were greater
than −50 kcal/mol. Previous studies have shown that when the
G90 fetal lung
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secondary structure of a leader sequence is stable (−50 kcal/mol) there
can be an 85–95% reduction in the translation compared to transcripts
with unstable secondary structures (Kozak, 1986). Numerous studies
have shown that alternative splicing is one mechanism whereby a
long and GC rich 5′ UTR that encodes a stable secondary structure can
be truncated resulting in a reduction in the stability of the leader
Adult lung
G90 fetal liver G90 fetal lung
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sequence's secondary structure and in turn enhance protein translation
(Charron et al., 1998; Delgado-Reyes et al., 2001; Han et al., 2003;
Sasahara et al., 1998). This phenomena appears to be occurring with
respect to bhmt expression since the 162 bp leader sequence ob-
served in the heart (SV5 and SV6, 61% GC content) was predictably
more stable than the 77 bp leader sequence detected in the liver
(SV1, 52% GC content). However, the 5′ UTR in brain (SV7) is only
3 bp shorter than the dominant liver isoform (SV1) and shares similar
secondary structures and free energies, and yet brain, unlike liver,
does not express significant levels of BHMT activity indicating other
mechanisms besides 5′ UTR structure and stability inhibiting BHMT
mRNA expression must be present in brain tissue. Overall, however, it
is likely that the spatial and temporal differences in BHMT enzyme ex-
pression across tissues are in part due to factors associated with bhmt
transcript variations within 5′ UTRs.
The 3′ UTRs of the bhmt transcripts also displayed considerable var-
iation (Fig. 2, Table 2). It is interesting to note that those organs that
expressed low or negligible levels of BHMT activity (kidney medulla,
lungs, heart, brain) expressed transcripts with significantly shorter 3′
UTRs compared to the liver and kidney cortex, whose dominant variant
(SV1) have the longest 3′ UTR, and highest levels of BHMT mRNA and
activity.
In general, miRNA functions by degrading the transcript and/or
translational repression (Bartel, 2009). Using miRNA predicting soft-
ware, a potential miRNA binding site has been identified in murine
bhmt 3′ UTR and this miRNA site is conserved in SV1 and SV8.
These data suggest that the length of the 3′ UTR in the different bhmt
SV affects transcript stability and subsequent level of protein expression
(Gaidatzis et al., 2007; Majoros and Ohler, 2007; Thiele et al., 2006;
Thorrez et al., 2010).
The expression of bhmt transcripts and BHMT activity was highest in
adult pig liver and kidney cortex in accordance to previous findings
(Delgado-Reyes et al., 2001; Ganu et al., 2011; Sunden et al., 1997).
Even though bhmt transcripts were detected in kidney medulla, lungs,
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heart and brain, negligible levels of enzyme activity were detected in
these organs except for low levels in the brain. The bhmt transcripts
and enzyme activity were developmentally regulated. There was a
clear trend of increasing bhmt transcript expression and enzymeactivity
with age in the liver, and the magnitude of mRNA expression and
enzyme activity in adult liver was approximately 100 times higher
when compared to fetal liver. It is currently unknown what factors
(dietary or environmental) stimulate BHMT expression following birth,
or conversely, repress fetal expression.
The variants that encode tBHMT represented 5–13%of the total bhmt
mRNA found in G30 fetuses, G45 liver, adult liver and kidney cortex.
This suggests that tBHMT could be translated at significant levels in
adult liver and kidney cortex, but we were unable to determine if it
was present in these organs because our polyclonal antibodies against
BHMT do not recognize a peptide smaller than 45 kD in crude pig
liver or kidney extracts (Delgado-Reyes and Garrow, 2005). An in silico
model of tBHMT suggests that this hypothetical proteinwould assume a
horseshoe fold rather than the wild type (β/α)8 barrel characteristic of
BHMT enzymes (Evans et al., 2002; Gonzalez et al., 2004). If expressed
and stable, tBHMT would not be a Hcy methyltransferase since it lacks
residues required for Zn binding, which prevents the protein's ability
to bind Hcy (Breksa and Garrow, 2002; Castro et al., 2004; Evans et al.,
2002). Generally, proteins that assume a horseshoe fold function as
chaperones or inhibitors, for example ribonuclease inhibitor protein
(Papageorgiou et al., 1997), and so it is possible that the tBHMT dem-
onstrates chaperone or protein inhibitor functions. Recently a study
demonstrated a bhmt splice variant in hepatic cancer that caused a
frameshift in exon 4 resulting in a termination codon (Pellanda et al.,
2012). This variant was not observed in healthy liver, and hence was
not isolated by our study.
The methylation of DNA, RNA, and histone proteins are known to
have significant affects on gene expression and phenotype (Niemitz
and Feinberg, 2004; Wolff et al., 1998; Xin et al., 2003). Specifically
methylation of CpG islands generally within the promoter and/or
overlap critical transcription factor binding sites decreases gene
transcription when they were found. Both these factors seem to
affect the spatial expression of the BHMT gene. The methylation status
of the BHMT gene in adult liver was five times lower than observed in
adult lungs, and the latter organ expresses significantly lower levels of
bhmtmRNA. Recently, a study demonstrated that global DNA hypome-
thylation in fetal brain was correlated to neural tube defect-associated
pregnancy (Chen et al., 2010). Hyperhomocysteinemia has been as-
sociated with neural tube defects and loss of BHMT function causes
hyperhomocysteinemia. Therefore it would be interesting to deter-
mine if BHMT is expressed in the neural tube and if methylation sta-
tus of the bhmt gene is associated with neural tube closure.
In summary, the results reported herein indicate that many organs
express different variants of bhmt, and that by far the highest levels of
BHMT mRNA in pigs was observed in the liver and kidney cortex. The
discovery of bhmt splice variants that differ in their 5′ and 3′ UTRs, in
combination with the variation observed in the methylation status of
the BHMT gene in different organs are likely factors affecting the organ
distribution of BHMT activity.
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